Markets

Market

News Details

(04/12/2025 12:10)

Corona Remedies announces launch of initial public offering

Corona Remedies Ltd. has announced public offering of 6171102 shares at a price of Rs 10.00 each for Cash at a Premium of Rs 1,052.00 per share. The gross proceeds of the issue are expected to be Rs 65,537.10 lakhs.

The company's initial public offer (IPO) will open on 08 December 2025 and is expected to close on 10 December 2025, subject to customary closing conditions. The price band of the issue has been fixed at Rs 1,008.00-1,062.00 per share.

The IPO includes a fresh Issue of 6171102 Equity Shares of the Company at an price of Rs 1,062.00 per Equity Share. The company has fixed the minimum bid lot for the issue at 14 shares with bids in multiples of 14.

Corona Remedies Ltd. anticipates using the proceeds of the issue for .

Kotak Mahindra Capital Company Limited,JM Financial Limited,IIFL Capital Services Limited as lead manager(s) & Bigshare Services Pvt. Ltd. is the registrar, to the issue.

Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remain in investor's account.